| Financial Year |
March 31 2023 |
| Monetary Funds |
3,420,188,280.55 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
667,337,609.12 |
| Accounts Receivable |
3,785,331,566.63 |
| Advances to Suppliers |
1,523,885,718.45 |
| Other Receivables |
1,190,745,164.17 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
6,035,805,081.97 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
230,012,893.32 |
| Other Current Assets |
1,731,135,886.80 |
| Total Current Assets |
20,412,623,617.50 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
13,055,660.00 |
| Long-term Equity Investment |
1,641,283,649.92 |
| Investment Properties |
360,243,205.59 |
| Fixed Assetes |
15,851,718,286.31 |
| Under-construction Projects |
13,065,060,704.96 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,869,095,364.99 |
| R&D expenses |
28,239,800.97 |
| Goodwill |
2,334,023,766.66 |
| Long-Term Deferred and Prepaid Expenses |
207,316,685.43 |
| Deferred Income Tax Assets |
823,406,334.02 |
| Other Non-Current Assets |
320,060,166.16 |
| Sub-Total of Non-Current Assets |
37,844,107,440.14 |
| Total Assets |
58,256,731,057.64 |
| Short-Term Loans |
2,740,829,135.17 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,352,813,215.52 |
| Accounts Payable |
7,237,152,710.88 |
| Accounts Received In Advance |
9,263,101.29 |
| Employee Compensation Payable |
108,943,044.01 |
| Taxes Payable |
339,454,692.61 |
| Interest Payable |
-- |
| Dividend Payable |
18,905,945.77 |
| Other payables |
1,252,940,289.31 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
425,795,302.22 |
| Other Current Liabilities |
1,318,055,457.40 |
| Sub-Total of Current Liabilities |
17,230,612,540.71 |
| Long-term Loans |
10,794,962,503.16 |
| Bonds Payable |
4,296,258,022.31 |
| Long-Term Accounts Payable |
1,282,571.43 |
| Special Payable |
-- |
| Estimatied Liabilities |
131,333,859.46 |
| Deferred Income Tax Liabilities |
475,043,203.64 |
| Other Non-Current Liabilities |
87,772,722.58 |
| Sub-Total of Non-Current Liabilities |
16,100,721,940.00 |
| Total Liabilities |
33,331,334,480.71 |
| Paid-In Capital(Or Share Stock) |
3,591,616,773.00 |
| Capital Surplus |
5,607,627,008.39 |
| Surplus Reserve |
979,098,890.49 |
| LESS:Treasury Stock |
109,533,760.00 |
| Undistributed Profits |
8,157,429,421.35 |
| Minority Stockholder's Interest |
6,135,294,316.76 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
18,790,102,260.17 |
| Owner's Equity（Stockholder's Equity） |
24,925,396,576.93 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
58,256,731,057.64 |
